AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9285285 — intervention group
Group type: EXPERIMENTAL
Intervention: Sferics exposure in subjects with high weather sensitivity, somatic complaints, and neuroticism
Number of subjects: 20
Study 8279224 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen exposure (2.8 atm, 100% O2, 60 min daily for 10 days)
Number of subjects: 0
Study 8279224 — intervention group
Group type: COMPARATOR
Intervention: Air exposure (control group)
Number of subjects: 0
Study 3519240 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.085 mg/kg bambuterol b.i.d.
Number of subjects: 19
Study 3519240 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.170 mg/kg bambuterol b.i.d.
Number of subjects: 19
Study 3519240 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.34 mg/kg bambuterol b.i.d.
Number of subjects: 19
Study 3519240 — intervention group
Group type: COMPARATOR
Intervention: 0.071 mg/kg terbutaline t.i.d.
Number of subjects: 19
Study 3291897 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil or hydralazine as monotherapy or with propranolol and/or hydrochlorothiazide
Number of subjects: 121
Study 30626597 — intervention group
Group type: EXPERIMENTAL
Intervention: MOVI-KIDS intervention (three 60 min sessions/week from October 2013 to May 2014)
Number of subjects: 1434
Study 30626597 — intervention group
Group type: EXPERIMENTAL
Intervention: MOVI-KIDS intervention
Number of subjects: 1434
Study 31519288 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi intervention (1-hour class, twice a week for 12 weeks, plus 30-minutes home practice three times per week)
Number of subjects: 35
Study 31519288 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained usual daily activities)
Number of subjects: 35
Study 28164396 — intervention group
Group type: EXPERIMENTAL
Intervention: 5α-reductase inhibitors (5-ARIs)
Number of subjects: 20
Study 28164396 — intervention group
Group type: COMPARATOR
Intervention: Control (Untreated)
Number of subjects: 20
Study 26607669 — intervention group
Group type: EXPERIMENTAL
Intervention: PERC-based strategy
Number of subjects: 0
Study 26607669 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 23243167 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried Distillers Grains Plus Solubles (DDGS)
Number of subjects: 198
Study 23243167 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn Silage-Based Soybean Meal (CSBM)
Number of subjects: 198
Study 23243167 — intervention group
Group type: COMPARATOR
Intervention: Corn Gluten Feed (CGF)
Number of subjects: 198
Study 20490671 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic treatment
Number of subjects: 54
Study 20490671 — intervention group
Group type: COMPARATOR
Intervention: Open surgical treatment
Number of subjects: 54
Study 18309613 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber-reinforced composite (FRC) layer at the adhesive interface
Number of subjects: 60
Study 18309613 — intervention group
Group type: COMPARATOR
Intervention: No fiber-reinforced composite (FRC) layer at the adhesive interface
Number of subjects: 60
Study 16817617 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuzzy logic applied to diffusion tensor images of the human spinal cord
Number of subjects: 0
Study 16817617 — intervention group
Group type: COMPARATOR
Intervention: Traditional fractional anisotropy index
Number of subjects: 0
Study 12621507 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral valacyclovir 500 mg twice daily until resolution of neutropenia
Number of subjects: 60
Study 12621507 — intervention group
Group type: COMPARATOR
Intervention: Oral acyclovir 600 mg every 6 h until resolution of neutropenia or acyclovir 125 mg/m(2) intravenously every 6 h
Number of subjects: 60
Study 11035320 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cerclage
Number of subjects: 67
Study 11035320 — intervention group
Group type: COMPARATOR
Intervention: Observational group
Number of subjects: 67
Study 11035320 — intervention group
Group type: COMPARATOR
Intervention: Observational group with cervical length <25 mm
Number of subjects: 67
Study 11035320 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic cerclage
Number of subjects: 67
Study 11035320 — intervention group
Group type: COMPARATOR
Intervention: No cerclage (in secondary random assignment)
Number of subjects: 67
Study 9331192 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-assisted debridement
Number of subjects: 80
Study 9331192 — intervention group
Group type: COMPARATOR
Intervention: Mechanical debridement
Number of subjects: 80
Study 8404101 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of a polyvalent bacterial extract (BE), 7 mg from eight different bacterial strains, taken as one capsule daily for the first 10 days of 3 consecutive months.
Number of subjects: 20
Study 8404101 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of a polyvalent bacterial extract (BE).
Number of subjects: 20
Study 8404101 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group).
Number of subjects: 20
Study 3807474 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg piretanide with 40 mg hyoscine‐N‐butylbromide (HNB)
Number of subjects: 5
Study 3807474 — intervention group
Group type: COMPARATOR
Intervention: 6 mg piretanide without HNB
Number of subjects: 5
Study 31875494 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence from alcohol
Number of subjects: 140
Study 31875494 — intervention group
Group type: COMPARATOR
Intervention: Control (continued usual alcohol consumption)
Number of subjects: 140
Study 29631567 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 299
Study 29631567 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-based stress management (ACT-bsm)
Number of subjects: 299
Study 29631567 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 299
Study 29631567 — intervention group
Group type: COMPARATOR
Intervention: Exercise and Control groups
Number of subjects: 299
Study 28419255 — intervention group
Group type: EXPERIMENTAL
Intervention: Unannounced surveys
Number of subjects: 23
Study 28419255 — intervention group
Group type: COMPARATOR
Intervention: Announced surveys
Number of subjects: 23
Study 26285704 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation (RDA)
Number of subjects: 400
Study 26285704 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 23663152 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified method for complete denture fabrication
Number of subjects: 42
Study 23663152 — intervention group
Group type: COMPARATOR
Intervention: Conventional method for complete denture fabrication
Number of subjects: 42
Study 21435970 — intervention group
Group type: EXPERIMENTAL
Intervention: Overlay group (augmented reality image overlay and laser guidance)
Number of subjects: 40
Study 21435970 — intervention group
Group type: COMPARATOR
Intervention: Control group (classical freehand insertions)
Number of subjects: 40
Study 18644424 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG-triggered neuromuscular electrical stimulation (NMES; EMG-stim) applied to the wrist extensor for two sessions (30 min/session) a day, five times per week for 10 weeks.
Number of subjects: 14
Study 18644424 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 14
Study 16431002 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaneka Q10 300 mg/day
Number of subjects: 88
Study 16431002 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaneka Q10 600 mg/day
Number of subjects: 88
Study 16431002 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaneka Q10 900 mg/day
Number of subjects: 88
Study 16431002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 12783234 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva cortisol (C) during competition
Number of subjects: 20
Study 12783234 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva testosterone (T) during competition
Number of subjects: 20
Study 12783234 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva cortisol (C) during recovery period
Number of subjects: 20
Study 12783234 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva testosterone (T) during recovery period
Number of subjects: 20
Study 12783234 — intervention group
Group type: EXPERIMENTAL
Intervention: T/C ratio during recovery period
Number of subjects: 20
Study 12783234 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery period duration
Number of subjects: 20
Study 10791524 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic radiotherapy (46 Gy)
Number of subjects: 715
Study 10791524 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 715
Study 9279065 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition
Number of subjects: 0
Study 9279065 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition
Number of subjects: 0
Study 7901059 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole (2 g oral dose)
Number of subjects: 100
Study 3528725 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftidrofurylhydrogenoxalate (Dusodril) as adjunctive therapy
Number of subjects: 60
Study 3528725 — intervention group
Group type: COMPARATOR
Intervention: Control group (dextran‐40 infusions)
Number of subjects: 60
Study 29565630 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy massage
Number of subjects: 60
Study 29565630 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy inhalation
Number of subjects: 60
Study 29565630 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 29565630 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy massage and inhalation
Number of subjects: 60
Study 28253062 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive feedback
Number of subjects: 120
Study 28253062 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomy-supportive style
Number of subjects: 120
Study 28253062 — intervention group
Group type: COMPARATOR
Intervention: Negative feedback
Number of subjects: 120
Study 28253062 — intervention group
Group type: COMPARATOR
Intervention: Controlling style
Number of subjects: 120
Study 23631746 — intervention group
Group type: EXPERIMENTAL
Intervention: Free gingival graft (FGG)
Number of subjects: 60
Study 23631746 — intervention group
Group type: COMPARATOR
Intervention: Maintenance (M) group (Control)
Number of subjects: 60
Study 23650781 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin-pegylated interferon alpha 2a
Number of subjects: 50
Study 23650781 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D control group (healthy subjects)
Number of subjects: 50
Study 20883981 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Lifestyle Triple P
Number of subjects: 101
Study 20883981 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 101
Study 18037598 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved high-performance liquid chromatography method with fluorescence detection (HPLC-FLU) for quantification of tamoxifen and metabolites
Number of subjects: 0
Study 18037598 — intervention group
Group type: EXPERIMENTAL
Intervention: Single stage liquid-liquid extraction method
Number of subjects: 0
Study 16831798 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational visits by a trained nurse (single 40-minute visit)
Number of subjects: 523
Study 16831798 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational visits by a trained nurse (single 40-minute visit) among non-smoking physicians
Number of subjects: 523
Study 16831798 — intervention group
Group type: COMPARATOR
Intervention: Control group (no visit)
Number of subjects: 523
Study 16831798 — intervention group
Group type: COMPARATOR
Intervention: Control group (no visit) among non-smoking physicians
Number of subjects: 523
Study 12730475 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron and folate supplements
Number of subjects: 0
Study 12730475 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 0
Study 12730475 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil and vitamins E and C
Number of subjects: 0
Study 12730475 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A and beta-carotene
Number of subjects: 0
Study 12730475 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional advice, magnesium, fish oil and zinc supplementation
Number of subjects: 0
Study 12730475 — intervention group
Group type: COMPARATOR
Intervention: No specific nutrient supplementation
Number of subjects: 0
Study 10750851 — intervention group
Group type: EXPERIMENTAL
Intervention: Open application model with supervised washing and at-home use of test products.
Number of subjects: 0
Study 10750851 — intervention group
Group type: EXPERIMENTAL
Intervention: Washing with surfactants on the dorsal hand and volar forearm.
Number of subjects: 0
Study 10750851 — intervention group
Group type: EXPERIMENTAL
Intervention: Squamometry as an assessment method.
Number of subjects: 0
Study 8911878 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (50 micrograms three times daily, total dose 150 micrograms)
Number of subjects: 7
Study 8911878 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (62.5 micrograms continuous infusion 24/h)
Number of subjects: 7
Study 8911878 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (112.5 micrograms continuous infusion 24/h)
Number of subjects: 7
Study 8911878 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (113 micrograms continuous infusion)
Number of subjects: 7
Study 8911878 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (all doses)
Number of subjects: 7
Study 1816439 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril, 50 mg
Number of subjects: 60
Study 1816439 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin, 2 mg
Number of subjects: 60
Study 1816439 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine, 20 mg
Number of subjects: 60
Study 6125198 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release aminophylline tablets
Number of subjects: 20
Study 6125198 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled rimiterol
Number of subjects: 20
Study 6125198 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30247640 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month intervention (n=30)
Number of subjects: 61
Study 30247640 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=31)
Number of subjects: 61
Study 27914903 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 470
Study 27914903 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term psychoanalytical therapy
Number of subjects: 470
Study 27914903 — intervention group
Group type: COMPARATOR
Intervention: Brief psychosocial intervention
Number of subjects: 470
Study 26432671 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin users (15% of hypertensive subjects, >3 months use)
Number of subjects: 1265
Study 26432671 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin users (79% of diabetic subjects, high-sodium diet)
Number of subjects: 1265
Study 23631970 — intervention group
Group type: EXPERIMENTAL
Intervention: Jasper jumper appliance followed by fixed appliances
Number of subjects: 72
Study 23631970 — intervention group
Group type: EXPERIMENTAL
Intervention: Activator-headgear combination followed by fixed appliances
Number of subjects: 72
Study 23631970 — intervention group
Group type: COMPARATOR
Intervention: Untreated subjects (control group)
Number of subjects: 72
Study 21810115 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 1000
Study 21810115 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 1000
Study 21810115 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac (Control in CONDOR)
Number of subjects: 1000
Study 19343426 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidental finding (metastatic gallbladder cancer)
Number of subjects: 15
Study 19343426 — intervention group
Group type: EXPERIMENTAL
Intervention: Iatrogenic injury (common bile duct injury)
Number of subjects: 15
Study 19343426 — intervention group
Group type: EXPERIMENTAL
Intervention: Senior residents (PGY4-PGY5)
Number of subjects: 15
Study 19343426 — intervention group
Group type: EXPERIMENTAL
Intervention: All residents
Number of subjects: 15
Study 16924007 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 155
Study 16924007 — intervention group
Group type: COMPARATOR
Intervention: Endovascular treatment
Number of subjects: 155
Study 16924007 — intervention group
Group type: EXPERIMENTAL
Intervention: SAH patients
Number of subjects: 155
Study 14991686 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam 6 mg from Medley SA Indústria Farmacêutica (test formulation)
Number of subjects: 24
Study 14991686 — intervention group
Group type: COMPARATOR
Intervention: Lexotan 6 mg from Produtos Roche Químico e Farmacêutico SA (reference formulation)
Number of subjects: 24
Study 11713622 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg triazolam
Number of subjects: 40
Study 11713622 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg triazolam
Number of subjects: 40
Study 11713622 — intervention group
Group type: COMPARATOR
Intervention: 0.0 mg (placebo)
Number of subjects: 40
Study 9392465 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed information before MRM (n=144)
Number of subjects: 336
Study 9392465 — intervention group
Group type: COMPARATOR
Intervention: Routine information before MRM (n=189)
Number of subjects: 336
Study 9392465 — intervention group
Group type: COMPARATOR
Intervention: Standard MRI (n=5837)
Number of subjects: 336
Study 7491369 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline or Imipramine (SSRI or tricyclic antidepressant)
Number of subjects: 212
Study 7491369 — intervention group
Group type: COMPARATOR
Intervention: Imipramine (150 mg/day for at least 4 consecutive weeks)
Number of subjects: 212
Study 7491369 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Major Depression
Number of subjects: 212
Study 2328551 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% tretinoin cream with 2% topical minoxidil solution
Number of subjects: 19
Study 2328551 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control cream with 2% topical minoxidil solution
Number of subjects: 19
Study 2328551 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% tretinoin cream
Number of subjects: 19
Study 2328551 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin biopsy analysis
Number of subjects: 19
Study 535860 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam (10 g i.v./h)
Number of subjects: 26
Study 535860 — intervention group
Group type: COMPARATOR
Intervention: Laevulose (placebo infusion)
Number of subjects: 26
Study 31473029 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Care Model for depression management
Number of subjects: 0
Study 30972889 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysglycemia Cluster 3 (n = 40, 17.1%)
Number of subjects: 234
Study 30972889 — intervention group
Group type: EXPERIMENTAL
Intervention: High HbA1c
Number of subjects: 234
Study 28810895 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster randomised crossover design
Number of subjects: 0
Study 28810895 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample size calculations for CRXO trials
Number of subjects: 0
Study 24635059 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure education program
Number of subjects: 60
Study 24635059 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 24577773 — intervention group
Group type: EXPERIMENTAL
Intervention: Low pressure group (LP) with CO2 pneumoperitoneum pressure maintained at 8-10 mmhg
Number of subjects: 48
Study 24577773 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle pressure group (MP) with CO2 pneumoperitoneum pressure maintained at 11-13 mmhg
Number of subjects: 48
Study 24577773 — intervention group
Group type: EXPERIMENTAL
Intervention: High pressure group (HP) with CO2 pneumoperitoneum pressure maintained at 14-16 mmhg
Number of subjects: 48
Study 24577773 — intervention group
Group type: COMPARATOR
Intervention: Open gastrectomy group (OG)
Number of subjects: 48
Study 21476099 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 28
Study 21476099 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep oscillation
Number of subjects: 28
Study 21476099 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting group untreated for vasculopathy)
Number of subjects: 28
Study 20456192 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical capsaicin 0.1%
Number of subjects: 23
Study 20456192 — intervention group
Group type: COMPARATOR
Intervention: Vaseline jelly
Number of subjects: 23
Study 17408990 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial venous surgery plus compression
Number of subjects: 185
Study 17408990 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited surgery under local anaesthesia (LA)
Number of subjects: 185
Study 17408990 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 185
Study 15711989 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated bouts of 10‐s static stretches of the wrist flexors
Number of subjects: 57
Study 15711989 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stretching)
Number of subjects: 57
Study 12477473 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled appointment for sigmoidoscopy by a nurse
Number of subjects: 2000
Study 12477473 — intervention group
Group type: COMPARATOR
Intervention: Instructed to call themselves for sigmoidoscopy
Number of subjects: 2000
Study 12477473 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy after sigmoidoscopy
Number of subjects: 2000
Study 9422303 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with lidocaine 50 mg/ml 1.5‐2 ml in 7.5% glucose through a 27‐G Quincke needle (Group S)
Number of subjects: 91
Study 9422303 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia with mepivacaine 20 mg/ml and epinephrine 5 microg/ml, 15‐20 ml (Group E)
Number of subjects: 91
Study 9422303 — intervention group
Group type: COMPARATOR
Intervention: Propofol anaesthesia with a bolus induction of 2 mg/kg followed by infusion (Group P)
Number of subjects: 91